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Abstract The aim of this study was to investigate genetic
selection and P-glycoprotein (PGP) expression in three differ-
ent isolates of Cooperia oncophora before treatment and after
ivermectin (IVM) injection. Adult parasites were recovered
from nine calves experimentally infected with the isolates
represented by one IVM susceptible laboratory isolate, and
two field isolates showing signs of phenotypic macrocyclic
lactone resilience according to the faecal egg count reduction
test. Five males and five females per isolate were examined
both pre- and post-IVM treatment giving a total of 60worms. A
sequence from C. oncophora (Con-pgp) was identified, show-
ing 83 % similarity to Pgp-9 of Caenorhabditis elegans.
Primers specific to putative Con-pgp-9 mRNAwere designed,
generating a 153-bp PCR product. Total RNA was prepared
from all worms, and Con-pgp-9 expression was measured by
quantitative real-time reverse transcription PCR. Our results
showed that mean PGP concentrations were four to five times
higher in female as compared to male worms. No significant
differences in gene expression between experimental groups
pre- and post-IVM selection were detected. However, PGP
gene expression tended to be increased by IVM treatment in
male worms (p=0.091), with 70 % higher mean expression in
treated than in untreated male worms. Amplified fragment
length polymorphism analysis did not demonstrate any bottle-
neck effect within the different isolates post-treatment. The
total mean gene diversity values were 0.158 and 0.153 before
and after treatment, respectively. Inbreeding coefficient in sub-
populations compared to total population FST was 0.0112,
suggesting no genetic differentiation between or within the
investigated isolates in relation to treatment. In conclusion,
comparison of Con-pgp-9 expression showed no significant
difference before and after treatment, but some tendency to-
wards increasing expression in male worms.
Introduction
Infections with parasitic gastrointestinal nematodes (GIN)
are common among grazing cattle worldwide, and may cause
serious economic losses due to decreased growth of their
hosts (Sutherland and Leathwick 2011). In Sweden, the most
important GIN species include Cooperia oncophora (Fig. 1)
and the more pathogenic Ostertagia ostertagi, which usually
are present as mixed infections in grazing cattle (Höglund
2010). Regular strategic treatment with anthelmintic drugs,
as topical or injectable formulations, remains the principal
means of control of helminth infections (Prichard et al.
2007). Lately, reports have shown that a worldwide spread
of anthelmintic resistance (AR) has occurred, probably due
to an extensive usage of anthelmintics in the cattle livestock
industry (Demeler et al. 2009; Gasbarre et al. 2009; Suther-
land and Leathwick 2011). However, the underlying mech-
anisms of AR development in cattle nematodes remain es-
sentially unknown. It is understood that drug resistance can
arise in four different ways: a change in the molecular target
causing failure at the binding site, changes in drug metabo-
lism preventing activation or removing the drug, changes in
drug distribution in the target organism, or amplification of
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target genes that overcome drug action (Wolstenholme et al.
2004).
Ivermectin (IVM) is one of several anthelmintics in the
group of macrocyclic lactones (ML), which has been exten-
sively used in the control of parasitic nematodes of livestock
since they were introduced in the early 1980s (Omura 2008).
MLs act through irreversible binding to γ-aminobutyric acid-
and glutamate-gated chloride (GluCl) channels, causing
hyperpolarisation and thus paralysis of pharyngeal and somatic
muscle cells, leading to starvation and expulsion of worms
from the GI tract (Blackhall et al. 1998b, 2003; Martin et al.
1998; Rana and Misra-Bhattacharya 2013). It has been shown
for the model organism Caenorhabitidis elegans (Cully et al.
1994; Dent et al. 2000; Lynagh and Lynch 2010; McCavera
et al. 2007) as well as for C. oncophora (Njue et al. 2004) that
IVM resistance can be associated with mutations in GluCl,
resulting in receptor conformation changes and lowered sensi-
tivity to IVM. However, the mechanisms behind IVM resis-
tance are complex, and there are many studies that suggest the
involvement of P-glycoproteins (PGP). PGPs are part of a
larger superfamily of transmembrane efflux transporters that
have been implicated as a primary cause of anthelmintic resis-
tance both in C. elegans and in the abomasal sheep nematode
Haemonchus contortus (Blackhall et al. 1998a; James and
Davey 2009; Kerboeuf et al. 2003a). PGPs, for which IVM is
a well-known substrate (Kerboeuf and Guegnard 2011;
Lespine et al. 2008), are members of the ATP binding cassette
(ABC) superfamily of genes coding for molecules involved in
active transport of endo- and exogenous hydrophobic mole-
cules (Jones and George 2005). Dupuy et al. (2010) showed
that PGPs are involved in the pharmacokinetics of IVM, and
recently Kerboeuf and Guegnard (2011) found evidence that
MLs activate transport activity in nematode PGP, and suggest
that several substituents in the ML structure are involved in
modulating the stimulatory effect. Altogether, 14 isoforms of
PGP plus 1 pseudogene have been annotated in the C. elegans
genome database (WormBase, version: WS234).
The majority of ML-resistance studies to date have inves-
tigated target site mutations. Some attention has been paid to
the role of changes in gene expression, and upregulation in
helminth PGP gene expression has been suggested to enhance
the parasite’s ability to survive exposure to IVM. The potential
effect of this may be an increased membrane transport and
thus faster drug elimination. Recently, PGP expression from
several variants of PGP in Teladorsagia circumcincta from
sheep was investigated in IVM-resistant isolates (Dicker et al.
2011). One of the PGP, Tci-Pgp-9, showed increased expres-
sion at the mRNA level and nucleotide sequences also showed
high levels of polymorphism, which could play an important
role in helminth survival of IVM exposure. Pachnicke (2009)
performed similar studies in a benzimidazole (BZ)-selectedO.
ostertagi population and found evidence of increased PGP-
related signals in eggshells from BZ-selected O. ostertagi, but
no signs of increased PGP gene expression in adult worms.
In the summers of 2006 and 2007, the efficacy of ML
(Ivomec inj.®) was investigated in five cattle herds in the
Uppsala region of central Sweden (Demeler et al. 2009).
The evaluation was made among first season grazing (FSG)
cattle some weeks after turnout, and was conducted using the
faecal egg count reduction test (FECRT). It showed unsatis-
factory efficacy results, with only one farm reaching accept-
able reductions of egg output in 2006. In 2007, the reduction
was insufficient on all farms where animals were treated with
IVM. Isolates from two of these farms were collected, and a
pen trial was carried out to investigate the effect of injectable
IVM under controlled conditions (unpublished data, Areskog
et al.). The objectives of the current study were to further
characterise the recovered worms in vitro and to compare
PGP expression in adult worms before and after treatment.
Materials and methods
Parasites
During 2009, an IVM selection trial was carried out where
three groups, each of 11 FSG, were experimentally inoculated
with mixtures of 40,000 infective third stage (L3) larvae of C.
oncophora and O. ostertagi. The study in its entirety will be
presented in a separate publication, but in brief, control group
A received an equal mixture of L3 from each of two laboratory
isolates from Tierärztliche Hochschule, Hannover, originating
from the Central Veterinary Laboratory at Weybridge, UK.
Both isolates had no history of being refractory to treatment
with any anthelmintics in vitro (Demeler et al. 2010). Calves
in groups B and C were inoculated with mixed L3 isolated
from the Swedish farms showing poor reductions to IVM
according to FECRT: 84 % [95 % confidence interval (CI),
67–95] and 85 % (62–99) reductions, respectively, at day 7
(Demeler et al. 2009). All animals were injected with IVM at
the standard dose rate of 0.2 mg IVM per kg 35 days post-
infection (d.p.i). Four days before IVM treatment (31 d.p.i),
Fig. 1 C. oncophora, bursa and spicules of adult male
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one animal per group (A, B and C) was euthanized intrave-
nously with pentobarbital (ex tempore 300mg/ml, 60ml/calf).
Another two animals per group were euthanized 10 days post-
IVM treatment (45 d.p.i). Individual faecal samples were also
collected rectally at the day of slaughter. A modified
McMaster method (Anonymous 1986) was used to determine
the number of parasite eggs in 3 g of faeces, giving a diag-
nostic sensitivity of 50 eggs per gram faeces (EPG). Animals
were treated, and the trial was performed according to formal
institutional ethical approval (C276/8).
At slaughter, worms were basically recovered according to
Larsson et al. (2007). Briefly, the abomasum and ∼7 m of the
proximal small intestine (duodenum, jejunum) were separated,
and their content emptied into individual vessels. The mucosal
surfaces were washed with tap water, and from each animal,
five male and five female adult worms were immediately
recovered and stored at –80 °C in individual Eppendorf tubes
until analysis. In addition, 20-ml aliquot subsamples were
collected and stored at –20 °C for worm counts and additional
analysis. Also, the abomasal mucosa was scraped off and
digested in a pepside solution for O. ostertagi recovery.
Isolation of RNA
Total worm RNA was isolated, using Macherey-Nagel
NucleoSpin RNA II columns with DNAse I, individually from
five single male and five female C. oncophora each pre- and
post (10 days) IVM treatment, from three different isolates,
giving in total 60 worms. The three isolates represented the
propagated susceptible control group plus two isolates showing
signs of phenotypic clinical ML resistance according to previ-
ous FECRT results. Washing buffers and rDNAse buffer were
used to remove contaminating DNA, and integrity of the RNA
was checked visually following electrophoresis. Eluates were
kept frozen at –80 °C for long-term storage. RNA quantifica-
tion was performed according to the RiboGreen protocol
(Invitrogen) using aVictor2 1420 Multilabel counter (Wallac).
Primer design
A conserved 202-bp PGP sequence from C. oncophora
(Pachnicke 2009) was identified by ClustalW2 as having
83 % similarity to the PGP-9 of C. elegans. Primers specific
to this conserved PGP sequence were then designed in Primer3,
generating a 153-bp PCR product. Sequencing of the PCR
product was performed, followed by a BLAST search in
Wormbase (genome view), which was identified as
WBGene00004003.
RT-qPCR
One-tube RT-PCRQuantiTect with SYBRGreen (Qiagen) was
used to measure PGP gene expression by RT-qPCR using
known concentrations of PGP-PCR product as standards and
non-template controls as blanks. The primer sequences used
were C. elegans Pgp-9 Forward 5′ CGA ACG AGG TGT
GCA ACT AA 3′ and C. elegans Pgp-9 Reverse 5′ GCC
TTC TCC AAA GCT TCT TGT 3′. The 25-μl RT-PCR re-
actions contained 12.5 μl 2× QIAGEN Quanti Tect SYBR
Green master mix, 0.5 μl Forward primer (10 μM), 0.5 μl
reverse primer (10 μM), 0.25 μl Q-RT, 1.25 μl of RNAse-free
H2O and 10μl RNA sample adjusted to contain 2 ng total RNA
from each single worm. Thus, PGP expression was normalised
to the amount of total RNA in the PCR reaction as previously
described by Tyden et al. (2009). All samples were run in
technical duplicates. To determine the level of expression of
PGPs before and after treatment, a standard curve was applied
using five concentrations of the purified and sequenced 153 bp
PGP-PCR product diluted from 7,000 to 0.7 ag μl−1 in tenfold
titrations. The PGP-PCR product was quantified by applying
PicoGreen reagent (Invitrogen) according to the instructions of
the manufacturer and a Victor2 1420 Multilabel counter
(Wallac). To minimise the risk of amplifying genomic DNA,
the samples were DNAse treated during RNA isolation, as
previously described.
RNA samples were run in a Rotor-Gene 3000 (Corbett)
and the data analysed using Rotor-Gene 6.1.90 software
(Corbett). The RT-qPCR conditions were as follows: RT step,
50 °C for 30 min; Taq-polymerase activation step, 95 °C for
15 min followed by 45 cycles of 94 °C for 60 s, 55 °C for 60 s
and 68 °C for 45 s and a final extension step at 68 °C for
7 min. Melting curve analysis was performed for each sample
in direct connection to the PCR, to verify that no secondary
products were generated. To quantify the relative changes in
expression of putative Con-pgp-9 before and after IVM treat-
ment, the 2−ΔCT method of Livak and Schmittgen (2001) was
used. In addition, in order to measure absolute Con-pgp-9
expression, absolute gene concentrations were also calculated
from the standard curve.
Amplified fragment length polymorphism
DNA extraction
DNA was prepared from individual worms using a QIAamp
DNA Micro Kit (Qiagen) according to the manufacturer’s
recommendation. Samples were eluted in 30 μl buffer AE.
Treatment with RNaseA was performed post-DNA isolation
by adding 60μg of RNaseA to 30μl of sample and incubating
for 5 min at room temperature to obtain RNA-free samples.
The purified DNAwas stored at −20 °C until use.
AFLP procedure
In total, 108 adult C. oncophora of both sexes were used for
AFLP analysis, but unlike the worms used for gene expression
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studies, these were recovered from aliquots frozen at −18 °C
(Table 1). The AFLP procedure was performed basically as
described by Applied Biosystems (ABI) in their Plant Map-
ping Protocol and in accordance with Höglund et al. (2004).
All reagents were supplied in the AFLP® Plant Mapping Kit
(ABI), except for the restriction enzymes and the T4 DNA
ligase, which were purchased from New England BioLabs.
For all worms, the maximum allowed volume, 5.5 μl, of
extracted DNA was used. The DNA from each individual
worm was digested with 1 unit of MseI and 5 units of EcoRI,
and MseI adaptor and EcoRI adaptor were ligated in the same
reaction as the digestion. After the restriction–ligation reac-
tion, the mixture was diluted to a total volume of 50 μl with
TE0.1 (20 mM Tris–HCl, 0.1 mM EDTA, pH 8.0). From the
restriction–ligation reaction, 4 μl of the diluted DNA was
mixed with 1 μl of the ABI pre-selective primer pairs
(5 μM) and 15 μl of ABI’s Core Mix for pre-selective ampli-
fication. The amplified products were diluted to a final volume
of 200 μl. The FAM dyed EcoRI-ACA+MseI-CTC primer
combination was used for selective amplification. From the
selective amplification products, 1.0 μl was mixed with 9.6 μl
deionised formamide and 0.4 μl GeneScan-500 size standard
(ABI). The mixture was denaturated for 3 min at 95 °C, before
being loaded onto the ABI Prism 3100 Genetic Analyzer and
analysed using GeneMapper analysis software 4.0.
Statistical analysis
Data were summarised in Microsoft Excel (2007), whereas
statistical analyses and graphs were done in Minitab (version
15). Gene expression was analysed by sex using both log
transformed- and original concentrations, and where we
compared duplicate mean concentrations, before and after
treatment with two sample t tests. In addition, a three-factor
ANOVA (GLM) comparing treatment×isolate×sex, with
isolate as a random factor, was performed. The significance
level was set to p<0.05.
The estimates of allele frequencies for each isolate used
the Bayesian method with informative priors of Zhivotovsky
(1999). The calculation of genetic diversity (Hj) and popu-
lation structure (Fst) from these estimates followed the pro-
cedures of Lynch and Milligan (1994), with 2,000 random-
izations used for the statistical tests. These statistics were all




Faecal egg counts revealed patent infections in all animals at
slaughter, both pre-treatment and 10 days post-IVM treatment
(Table 1). At necropsy, mainly low to moderate numbers ofC.
oncophora remained in the small intestines of all IVM-treated
animals (Table 1). The worm burden showed large variation
within groups and no significant difference (p=0.510) be-
tween groups.
RT-qPCR
The expression of the putative Con-pgp-9 before treatment
was compared to the results after treatment for each isolate,
and males and females separately. Reaction efficiency of the
Table 1 EPG data from day of slaughter and estimated numbers of adult worms recovered in 20 ml subsamples at necropsy, from calves before and
10 days after injection with ivermectin (Ivomec®, Merial) at a dose rate of 0.2 mg IVM/kg
Treatment Calf Origin O. ostertagi C. oncophora EPG
Males Females Males Females
Before IVM A1 TiHo 2,070 3,230 6,470 5,270 750
B1 Gråmunkehöga 570 670 9,070 13,600 1,000
C1 Kolsta 900 2,900 1,930 3,070 400
After IVM A2 TiHo 0 0 3,330 5,730 150
A3 TiHo 0 0 130 400 <50
B2 Gråmunkehöga 0 0 6,000 6,200 50
B3 Gråmunkehöga 100 0 200 200 <50
C2 Kolsta 0 0 600 1,600 <50
C3 Kolsta 0 0 1,000 2,000 <50
Calves were previously each inoculated with a mixture of 40,000 L3 of C. oncophora and O. ostertagi, representing isolates with different
deworming history. Calves A1, A2 and A3 were inoculated with equal mixtures of laboratory-maintained C. oncophora and O. ostertagi from TiHo,
whereas B1, B2, B3, C1, C2 and C3 were inoculated with cattle nematodes from two different farms in Uppland, Sweden, showing phenotypic
clinical IVM resistance in previous field trials. Ten worms from each calf were immediately recovered and stored separately at −80 °C for RT-qPCR,
and excessive worms were stored at −20 °C for AFLP analysis
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qPCR was 1.08 in females and 0.97 in males. All samples
had concentrations within the range of the standard curve,
and female worms had an approximately five times higher
gene expression compared to male worms before treatment
(Table 2).
The RT-qPCR results demonstrated that mean putative
Con-pgp-9 expression in ML-treated male worms was
70 % higher than in the untreated worms, with mean con-
centrations of 27 (±25)ag μl−1before treatment and 46.2
(±32)ag μl−1 after treatment, respectively (Table 2). Al-
though mean concentrations and boxplots (Fig. 2) suggested
a tendency for increased Con-pgp-9 gene expression after
treatment, the statistical analysis showed no significant dif-
ference (p=0.091).
In females, mean concentrations of PGP were 172 (±SD
of 124)ag μl−1 before treatment and 196 (±250)ag μl−1 after
treatment (Table 2). However, as with the male worms, no
significant difference (p=0.747) in concentrations was seen
in comparisons between any group pre- and post-selection
(Fig. 3).
The two-sample t test showed large variance within female
worm groups. Comparing sex and treatment gave no signifi-
cance (p=0.091 and p=0.747, respectively), but the three-factor
ANOVA, with isolate as a random factor, showed that the iso-
lates behaved very differently (p=0.006). Log transformed con-
centrations gave similar results (data not shown).
AFLP
AFLP showed no bottleneck effect within the population
after treatment, with mean gene diversity (Hj) values of
0.158 before treatment and 0.153 after treatment (Table 3).
Inbreeding coefficient (FST) in subpopulations compared to
the total population was 0.0112.
Discussion
In closely related GI nematodes of sheep, ML resistance has
been suggested to be linked to an overexpression of PGPs
(Blackhall et al. 1998a; Dicker et al. 2011; Williamson et al.
2011). Our hypothesis in this study was that changes in
expression of efflux pumps such as PGPs would be affected
in C. oncophora, which survive ML treatment, and/or in
isolates with different deworming histories. Increased ex-
pression of this molecule has previously been suggested to
play a role in drug resistance towards malaria, HIV and
cancer, and in nematodes, it has been connected to ML
resistance (Gupta and Gollapudi 1993; James and Davey
2009; Loo and Clarke 1999; Xu et al. 1998). Unlike most
studies previously performed, we made an attempt to mea-
sure PGP expression levels in individual adult worms of C.
Table 2 RT-qPCR results showing concentrations of putative Con-pgp-9 RNA expression (ag/2 ng total RNA) in isolates before and 10 days after
selection with injectable ivermectin at a dose rate of 0.2 mg ivermectin/kg body weight
Females Males
Isolate Median Mean SD Sign. p (95 % CI) Median Mean SD Sign. p (95 % CI)
All Before 153 172 124 20 27 25
After 83 196 250 0.747 44 46 32 0.091
A Before 122 121 38 42 39 7
After 458 420 343 0.125 44 44 35 0.764
B Before 155 154 37 13 29 41
After 83 108 65 0.213 48 41 21 0.571
C Before 301 242 203 17 17 9
After 55 60 33 0.119 40 54 43 0.137
Group A was infected with a propagated IVM-susceptible laboratory isolate, and groups B and C were infected with two different field isolates
showing phenotypic clinical IVM resistance in field trials
Fig. 2 Boxplot of quantitative putative Con-pgp-9 expression, males,
all groups, 15 worms before- and 15 worms after selection. Isolate A
was propagated IVM susceptible, whereas B and C were two different
field isolates showing phenotypic clinical IVM resistance in field trials
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oncophora, employing replicates reflecting the biological
diversity in PGP expression. Our results demonstrate a wide
distribution and no statistically significant differences in
Con-pgp-9 expression pre- and post-IVM treatment.
It has previously been reported that several anthelmintics may
cause an augmented PGP expression in various nematodes
(Pachnicke 2009; Williamson et al. 2011; Dicker et al. 2011).
The reasons for the discrepancy between our results and the ones
previously reported are speculative. However, one possible ex-
planation may include analyses of pooled samples missing the
biological diversity by performing statistics on technical repeats.
Also, use of BZ instead of IVM may influence the PGP expres-
sion in a different manner, or worm-specific sensitivity in the
upregulation of PGP. Thus, it cannot be excluded that C.
oncophora responds differently to anthelmintic treatment than
O. ostertagi (Pachnicke 2009), H. contortus (Williamson et al.
2011) and T. circumcincta (Dicker et al. 2011). It is also often
hypothesized that anthelmintic exposure itself induces expression
of ABC transporter genes in nematodes, experimental evidence is
still scarce (Ardelli and Prichard 2008; James and Davey 2009).
The results showed no significant differences before and
after ML treatment between the three C. oncophora isolates
(A, B and C), each with a different deworming history, possi-
bly due to small sample sizes. However, there was a tendency
towards increasing putative Con-pgp-9 expression in male
worms (p=0.091). Female worms seemed to give higher and
more variable results (p=0.747) than male worms, possibly
due to the presence of varying amounts of eggs also express-
ing PGP (Kerboeuf et al. 2003b; Riou et al. 2005). The non-
significant statistical results in the comparisons between sex
and treatment might be a result of different expression patterns
in the investigated isolates. For instance, females in groups B
and C actually reduced their meanCon-pgp-9 expression after
ML treatment. This was in contrast to all the other groups and,
hypothetically, it could be explained by a decrease in intra-
uterine egg production, and thus lower mRNA levels for
expression of PGP in egg shells during IVM influences. It
has previously been shown that the nematode uterine muscle
is one of the most susceptible target organs for MLs (Prichard
2001), which could mean that the drug may temporarily
suppress egg laying even though adult worms survive treat-
ment. This would make fecund female worms unsuitable for
investigation as it causes difficulties in distinguishing between
worm- and egg PGP expression levels. However, the same
situation did not seem to occur among females in the lab
isolate, group A. The differences between groups, rather than
differences before or after treatment, were also confirmed by
statistical analysis. Clearly, a larger sample size is required to
better ensure the effect of ML on individual worms, but the
sampling method is both labor-intensive, expensive and de-
mands euthanizing of animals to collect large number of
adults surviving deworming. Sometimes we also had prob-
lems to isolate enough RNA from the worms, especially from
the males, and the number of surviving worms was limited.
Our results therefore can neither support nor exclude that
Con-pgp-9 is involved in the increased incidence of resistance
to IVM in this cattle nematode, as has recently been reported
for T. circumcincta in sheep (Dicker et al. 2011). Another factor
that may explain the differing results is the time of sampling.
Pachnicke (2009) collected worms 7 days post-treatment, while
in other studies, it is unclear when donor animals were
sacrificed. In this study, we investigated worms 10 days post-
treatment; however, it is not known when would be the best
time to measure changes in Con-Pgp-9 expression after ML
treatment. In a most recently published investigation conducted
in parallel to this, De Graef et al. (2013) examined effects of
Table 3 AFLP results derived from adult worms showing high gene
diversity (Hj) values ranging between 0.139 and 0.169 in isolates before
and 10 days after selection with injectable IVM at a dose rate of 0.2 mg
IVM/kg
Isolate Sex N Hj before n Hj after
A M 7 0.16853 9 0.14800
F 8 0.15319 13 0.16727
B M 9 0.15288 10 0.13926
F 8 0.16733 9 0.15734
C M 8 0.14704 9 0.15325
F 5 0.15879 13 0.15225
45 0.15796 63 0.152895
Isolate Awas propagated IVM susceptible, whereas B and C were two
different field isolates showing phenotypic clinical IVM resistance in
field trials. Average within-population genetic diversity, measured as
expected heterozygosity or gene diversity; before and after is equal (Hj
=0.158 before and 0.153 after) and thus negatively related to population
bottleneck effect. Fst (inbreeding coefficient) due to non-randommating
in subpopulations relative to the total population, where 0=no differ-
entiation and 1=complete differentiation, is low (0.0112), suggesting
very little differentiation; Fst=0.0112
Fig. 3 Boxplot of quantitative putativeCon-pgp-9 expression, females,
all groups, 15 worms before- and 15 worms after selection. Isolate A
was propagated IVM susceptible, whereas B and C were two different
field isolates showing phenotypic clinical IVM resistance in field trials
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IVM treatment on the transcription of C. oncophora PGPs. In
agreement with our findings, no significant differences with
respect to Con-Pgp-9 expression were recorded between adults
of susceptible and IVM-resistant Belgian C. oncophora iso-
lates. Neither could any differences be seen between adults
from the resistant isolate being ML-exposed or unexposed.
However, in the latter adult worms, a 3.1- and 4.7-fold increased
expression of Con-Pgp-11 was encountered in association with
IVM and moxidectin, respectively, after in vivo exposure. Fur-
ther experiments are thus clearly required to verify the results
obtained in the present study, but also to elucidate additional
resistance mechanisms that may be involved.
When our C. oncophora isolates were analysed with AFLP,
we found no evidence of genetic bottlenecking in either of the
drug-selected worms, and by comparing their genetic makeup
pre- and post-treatment. In veterinary parasitology, AFLP has
previously been used mainly to compare the genetic structures
of various parasitic nematodes of livestock with different geo-
graphic backgrounds (Höglund et al. 2012, 2006; Nejsum et al.
2005; Troell et al. 2006), but also to compare consecutive
stages of increased benzimidazole- and levamisole-resistant
isolates during selection (Otsen et al. 2001). Höglund et al.
(2006) concluded that most nematodes of domesticated hosts
usually have very little genetic difference between populations,
and are characterised by strong gene flow and expanding
populations. In accordance with Otsen et al. (2001), we found
no significant changes in the genetic diversity of iso-
lates associated with anthelmintic selection. However, in
contrast to the high level of genetic variation in H.
contortus, our obtained C. oncophora inbreeding coefficient,
FST, was low, suggesting no genetic differentiation. This
agrees with the results from Höglund et al. (2006) and could
mean that, if genetic resistance establishes regionally,
then a rapid spread of resistance development would
be enabled within the equivalent genetic pool.
In conclusion, comparison of putative Con-pgp-9 ex-
pression before and after IVM treatment showed no
significant difference between the tested groups, but
some tendency towards increasing expression in male
as compared to female worms. Additional research is
required to elucidate whether AR observed in C.
oncophora involves increased expression and activity
of PGP or whether this is related to some other trans-
membrane efflux transporter or metabolic enzyme.
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